克洛斯特里迪奥伊德困难感染的免疫方面和疫苗开发
Rochelle C Glover1, F Christopher Peritore-Galve2, Borden Lacy3
1Division of Protective Immunity, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Infectious disease clinics of North America
|August 13, 2025
概括
开发新的Clostridioides difficile疫苗至关重要. 目前针对TcdA和TcdB毒素的疫苗已经失败,需要新的方法来预防感染和疾病.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 艰难菌感染 (CDI) 导致严重的胃肠道疾病,包括与抗生素相关的腹和伪膜性结肠炎.
- 病原发生主要由两个关键的外毒素介导:TcdA和TcdB.
- 针对这些毒素的现有候选疫苗在预防殖民或疾病方面没有取得成功.
研究的目的:
- 审查关于Clostridioides difficile病原和疫苗学的当前研究.
- 为开发下一代C. difficile疫苗提供一个框架.
主要方法:
- 基本和临床研究结果的审查.
- 对C. difficile病变的洞察力进行分析.
- 评估疫苗学方面的进展.
主要成果:
- 尽管先前有努力,但没有任何疫苗能够有效地预防C. difficile的殖民或疾病.
- 最近在了解病原体与宿主相互作用和免疫反应方面的进展为疫苗开发提供了新的途径.
结论:
- 下一代C. difficile疫苗需要创新的策略,而不仅仅是针对TcdA和TcdB.
- 为了有效预防CDI,进一步的研究整合了病原体洞察力和疫苗学进展是必不可少的.
相关概念视频
Microorganisms in Medicine and Therapeutics
330
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
330
Vaccinations
45.3K
Overview
45.3K
Development of Immunocompetence
448
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
448
Immunodeficiency Diseases
1.2K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.2K
Cross-reactivity
31.5K
Overview
31.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
271
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271


